Skip to content

Author

Fangkai He

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Integrated pharmacology and validation reveal Formononetin upregulates GSTM2 to modulate prostate cancer immune microenvironment via ROS/STAT3-driven chemokine reprogramming

Background Prostate cancer (PCa) is responsible for a substantial proportion of male cancer cases worldwide. Biochemical recurrence (BCR) representing a critical challenge in its disease management. Formononetin, a natural isoflavone derived from traditional Chinese medicine, has demonstrated potential anticancer prope...

Tian-Lun Yu, Yu Zhou, Fang-Kai He et al. · 0 citations
Review Open access Aug 2026

A Data-Driven Atlas of CAR-Based Immunotherapy in Lung Cancer: Insights from Multidatabase Integration.

A data-driven pharmacological atlas of CAR-based immunotherapy in lung cancer is furnished, illuminating key therapeutic targets, evolving treatment paradigms, and prospective opportunities for clinical translation.

Fangkai He, Xing-Yu Zhu, Xiao-Lei Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.